Navigation Links
Ansell Healthcare Receives CE Mark for GAMMEX® Powder-Free Gloves With AMT Antimicrobial Technology
Date:10/17/2011

BRUSSELS, October 17, 2011 /PRNewswire/ --

Novel Gloves First to be Classified as Class III Medical Devices

Ansell Healthcare, a global leader in healthcare barrier protection, announced today that it has received the CE Mark for GAMMEX® Powder-Free gloves with AMT Antimicrobial Technology. Through its unique virus and bacteria-killing technology, the novel GAMMEX® Powder-Free with AMT provides protection against some of the most common pathogens and drug-resistant bacteria in the event of a glove breach*. Ansell will commercially launch GAMMEX® Powder-Free gloves with AMT across Europe in the autumn of 2011.

"We look forward to bringing a new level of protection and peace of mind to the surgical staff," said Peter Dobbelsteijn, Senior Vice President EMEA, Ansell Healthcare. "GAMMEX® Powder-Free with AMT has its own immune system to fight back against pathogens that migrate through the breaches that inevitably occur in actual use."

The gloves, made of natural rubber latex, provide the same feel, sensitivity, flexibility and dexterity as conventional gloves when manipulating and handling instruments. The main difference is the active antimicrobial layer which contains chlorhexidine gluconate (CHG). This proprietary technology can provide ongoing antiviral and antibacterial protection against HIV, hepatitis C and infectious bacteria.

"The new GAMMEX® Powder-Free with AMT is a significant technical breakthrough in terms of bringing about a change from passive protection to active protection. These new gloves respond to the demands of healthcare workers in the surgical theatre who face infection risks every day. With AMT Antimicrobial Technology, we can offer healthcare workers an extra level of security. Glove breaches happen during surgery through the use of sharp instruments and with the AMT technology, Ansell provides for a backup plan," said David Lucas, Vice President Science & Techno
'/>"/>

SOURCE Ansell Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ansell Limited Acquires Sandel Medical Industries LLC, an Innovator in Surgical Safety Solutions
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. ViroPharma to Present at Three Upcoming Healthcare Conferences
5. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
6. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
7. Tablet PC Technology Helps Doctors and Patients Focus on Chemotherapy Side Effects, According to Thomson Healthcare Study
8. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
9. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
10. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
11. Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... N.C. , July 2, 2015 ... assets related to the ion channel biology platform from ... been obtained as part of Pfizer,s 2011 acquisition of ... rights to the "Icagen" name and trademark.  XRPro Sciences ... services for ion channel and transporter drug discovery, combining ...
(Date:7/2/2015)... 2015 Research ... addition of the "2015 New Frontiers ... Emerging Technologies, Competitive Landscape" report to ... in Clinical Chemistry and Immunodiagnostics: Global Challenges, ... seven-country strategic analysis of major business opportunities ...
(Date:7/2/2015)... BGI gab heute bekannt, dass ... American College of Pathologists (CAP) akkreditiert wurde. ... klinische Next-Generation-Sequencing Labor, das in ... somit die höchsten Standards an klinischer Laborpraxis ... - 21 CFR Part 11 konformen Laborverfahren ...
Breaking Medicine Technology:Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2BGI erhält Akkreditierung vom College of American Pathologists (CAP) 2
(Date:7/4/2015)... (PRWEB) , ... July 04, 2015 , ... ... the solar industry’s leading recognition of technical sales expertise from the North American ... Technical Sales ProfessionalTM. NABCEP is the most highly respected and well established national ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... registration for a new SEO training system called "Page One Engine" . ... traffic generation has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon and ... 2016 Dallas Rhinoplasty Symposium . To be held from March 4th - 6th, ... held at the Westin Galleria Dallas. , Designed to take participants from the basic ...
(Date:7/3/2015)... NY (PRWEB) , ... July 03, 2015 , ... ... Learning Lecture took place on June 25, 2015 at 1:00pm. The Association welcomed ... explored issues pertaining to injured bicyclists and practical points of investigating these types ...
(Date:7/3/2015)... ... 03, 2015 , ... Jennifer Renee Hanes, DO is the new Medical Director ... network of independent freestanding emergency rooms in the United States. , “We are excited ... facility,” said Executive Medical Director of First Choice Emergency Room, Dr. James M. Muzzarelli. ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 2Health News:Dr. Jennifer Renee Hanes Named by First Choice Emergency Room as Medical Director of Missouri City, TX Facility 3
... Worldwide Rights for its first NDA - AllerNaze(TM) , ... BLOOMBERG: LPC IN , , MUMBAI, India, June 30 ... worldwide rights for the intra-nasal steroid (INS) product, AllerNaze(TM) (triamcinolone ... , The United States will be the first market ...
... June 30 What can science and technology contribute to solving ... lot say 15 prominent scientists writing in a special 25th anniversary ... opens with a challenge from President Barack Obama for science to ... of life. Experts from across the globe respond. , ...
... Award Recognizes Campaign to Vaccinate 1.2 Million Americans - ... and MinuteClinic, CVS Caremark,s retail clinic division, have received ... for a Corporate Campaign. The award, co-sponsored by ... Control and Prevention, was presented yesterday evening in Dallas ...
... ... sex hurts. Most suffer in silence because they are too embarrassed or ashamed ... the genital area, urinary urgency, irritable bowel, low back pain (and many more), ... first time, a new book brings this taboo subject out of the closet, ...
... a diminished number of eggs in their ovaries, either because ... ovarian surgery, may be more at risk of a trisomic ... fertile range. Trisomic pregnancies occur when the embryo has ... The most common trisomy is Down,s syndrome or trisomy 21. ...
... , - Completion of Phase I Paves Way for Expanding ... Patients with Diverse Advanced Cancers Along with Promising Interim Phase ... , , TUSTIN, Calif., June 30 Peregrine Pharmaceuticals, ... has completed the planned patient enrollment in its U.S. Phase ...
Cached Medicine News:Health News:Lupin Expands Branded Play 2Health News:Lupin Expands Branded Play 3Health News:Articles by Prominent Scientists Featured in 25th Anniversary Issue 2Health News:CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit 2Health News:CVS/pharmacy and MinuteClinic Receive Award of Excellence from National Influenza Vaccine Summit 3Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 2Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 3Health News:First Book Focusing on How "The Secret Pain Women Won't Talk About" Affects Relationships 4Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 2Health News:Reduced ovarian reserve associated with increased risk of trisomic pregnancy 3Health News:Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 2Health News:Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 3Health News:Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial 4
Used after ablation to wash away particulate from anterior & posterior sides of flap & stromal bed. Conforms to the corneal flap. .0mm extension with a 11.0mm radius, Angled tip....
Smaller diameter wire probes & olive shape tips provide easier insertion through the lacrimal sac, 35cm (14 in) long, ID- .30mm (.012in); OD- .64mm (.025 in). S.S. Probes: .40mm x 11cm (27 G x 4 1/4...
...
...
Medicine Products: